{"id":"W1962960638","doi":"10.3109/10428194.2015.1091927","title":"A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191","year":2015,"lang":"en","type":"letter","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University of Alberta; Juravinski Cancer Centre; Saint John Regional Hospital; Dalhousie University; University of New Brunswick; Queen's University","funders":"","keywords":"Multiple myeloma; Medicine; Refractory (planetary science); Internal medicine; Oncology; Clinical trial; Kinase; Malignancy; Aurora A kinase; Aurora kinase; Cancer; Biology; Cell cycle","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002786228,0.001582107,0.003114028,0.0005675658,0.0002898625,0.0001228316,0.001076715,0.003644617,0.0000200275],"category_scores_gemma":[0.001173899,0.001270124,0.0004845459,0.0005616221,0.0005347579,0.00007756252,0.0007781238,0.0009274514,0.000008247511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002153442,"about_ca_system_score_gemma":0.005490752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001519388,"about_ca_topic_score_gemma":0.001536004,"domain_scores_codex":[0.98904,0.002587726,0.003456092,0.002581418,0.001093965,0.001240788],"domain_scores_gemma":[0.9939478,0.0004467214,0.002174763,0.002291235,0.0005477411,0.0005917447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.08062745,0.0414925,0.06162798,0.001294834,0.003278667,0.003343557,0.004248687,0.00005048581,0.01746058,0.000007906585,0.4092667,0.3773006],"study_design_scores_gemma":[0.3617333,0.1026763,0.02565707,0.0009641019,0.001644176,0.0001629324,0.001520394,0.0005813569,0.002600981,0.00003459407,0.4980756,0.004349212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943566,0.0007897493,0.00003060673,0.0002398727,0.0008591285,0.002972003,0.0005912554,0.00007197396,0.00008878932],"genre_scores_gemma":[0.9723452,0.0004055178,0.0004105082,0.01642477,0.002657592,0.0003587656,0.006224247,0.0003798742,0.0007934895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3729514,"threshold_uncertainty_score":0.9996927,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03363137153877019,"score_gpt":0.313103503236891,"score_spread":0.2794721316981208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}